Market Data Browsing: GSKs
The Food and Drug Administration on Friday expanded the approval of GSK’s respiratory syncytial virus vaccine to adults ages 50…
The Food and Drug Administration on Friday expanded the approval of GSK’s respiratory syncytial virus vaccine to adults ages 50…